joel topf October 27, 2015 Archive Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial joel topf October 27, 2015 Archive Summary | Pubmed | Storify | Symplur
